Skip to main content
Full access
Regular Article
Published Online: 1 August 1999

Risperidone Treatment of Behavioral Disturbances in Outpatients With Dementia

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

The authors retrospectively assessed the effectiveness and side effects of risperidone used to treat behavioral disturbances in elderly outpatients with dementia. In 41 patients treated with risperidone 1.8±1.4 mg/day, there was complete suppression of the target symptom in 15%, partial response in 41%, and no response in 44%. Risperidone appeared equally effective in treating agitation and psychosis. New or worsening extrapyramidal side effects (EPS) occurred in 32%, associated with longer duration of treatment and possibly with concomitant use of serotonergic antidepressants. Risperidone was a useful adjunct in the treatment of agitation and psychosis in outpatients with dementia but was limited by EPS in about one-third of patients.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 336 - 342
PubMed: 10440009

History

Published online: 1 August 1999
Published in print: August 1999

Authors

Details

Michael C. Irizarry, M.D.
Received December 9, 1998; revised March 5, 1999; accepted March 17, 1999. From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, The George Washington University, Washington, DC. Address correspondence to Dr. Irizarry, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, CNY 6028, 149 13th Street, Charlestown, MA 02129.
S. Nassir Ghaemi, M.D.
Received December 9, 1998; revised March 5, 1999; accepted March 17, 1999. From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, The George Washington University, Washington, DC. Address correspondence to Dr. Irizarry, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, CNY 6028, 149 13th Street, Charlestown, MA 02129.
Erica R. Lee-Cherry, B.A.
Received December 9, 1998; revised March 5, 1999; accepted March 17, 1999. From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, The George Washington University, Washington, DC. Address correspondence to Dr. Irizarry, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, CNY 6028, 149 13th Street, Charlestown, MA 02129.
Teresa Gomez-Isla, M.D., Ph.D.
Received December 9, 1998; revised March 5, 1999; accepted March 17, 1999. From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, The George Washington University, Washington, DC. Address correspondence to Dr. Irizarry, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, CNY 6028, 149 13th Street, Charlestown, MA 02129.
Giuliano Binetti, M.D.
Received December 9, 1998; revised March 5, 1999; accepted March 17, 1999. From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, The George Washington University, Washington, DC. Address correspondence to Dr. Irizarry, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, CNY 6028, 149 13th Street, Charlestown, MA 02129.
Bradley T. Hyman, M.D., Ph.D.
Received December 9, 1998; revised March 5, 1999; accepted March 17, 1999. From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, The George Washington University, Washington, DC. Address correspondence to Dr. Irizarry, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, CNY 6028, 149 13th Street, Charlestown, MA 02129.
John H. Growdon, M.D.
Received December 9, 1998; revised March 5, 1999; accepted March 17, 1999. From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, The George Washington University, Washington, DC. Address correspondence to Dr. Irizarry, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, CNY 6028, 149 13th Street, Charlestown, MA 02129.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share